Javascript must be enabled to continue!
Divergent pathways of melanoma development: evidence from a Southern European cohort
View through CrossRef
Nevus counts in the divergent pathway model of melanoma development have been studied mainly in patients in Australia. Our aim was to compare nevus counts and the melanoma subtype for melanomas arising on chronically sun-exposed body versus non-chronically sun-exposed body locations in Southern European patients. This was a retrospective study of prospectively collected data from 2013 to 2023 at a melanoma referral center in Athens, Greece, in patients diagnosed with invasive melanoma of the superficial spreading melanoma (SSM) or nodular melanoma subtype. Multivariate multinomial logistic regression analysis was performed. In 1252 patients with SSM or nodular melanoma, the median age (interquartile range) was 57 (46, 67) years old and 51% were males. Regarding nevus counts, 57.9% of patients had 0–25 nevi (low), while the remaining 42.1% had greater than 25 nevi (high). In multivariate analysis, those with greater than 25 nevi (versus ≤25) were significantly less likely to have melanoma developing on the head/neck (chronically sun exposed body site) [odds ratio (OR): 0.60, 95% confidence interval (CI): 0.38–0.93] or on the lower extremity (OR: 0.63, 95% CI: 0.44-–0.87), compared with having melanoma on the trunk (non-chronically sun exposed). Regarding the melanoma subtype, those with SSM versus nodular melanoma subtype were 53% less likely to have melanoma developing on the head/neck (OR: 0.47, 95% CI: 0.30–0.75), compared with the trunk. The melanoma subtype (SSM or nodular melanoma) did not significantly differ across upper extremity (OR: 0.94, 95% CI: 0.59–1.51) or lower extremity (OR: 1.03, 95% CI: 0.66–1.62) locations of melanoma development compared with the trunk. In conclusion, the association of higher nevus counts with melanomas developing on the trunk supports the divergent pathways of melanoma development in Southern European patients. Melanomas on the head/neck were significantly associated with lower numbers of nevi and were more likely to be nodular melanoma subtype.
Title: Divergent pathways of melanoma development: evidence from a Southern European cohort
Description:
Nevus counts in the divergent pathway model of melanoma development have been studied mainly in patients in Australia.
Our aim was to compare nevus counts and the melanoma subtype for melanomas arising on chronically sun-exposed body versus non-chronically sun-exposed body locations in Southern European patients.
This was a retrospective study of prospectively collected data from 2013 to 2023 at a melanoma referral center in Athens, Greece, in patients diagnosed with invasive melanoma of the superficial spreading melanoma (SSM) or nodular melanoma subtype.
Multivariate multinomial logistic regression analysis was performed.
In 1252 patients with SSM or nodular melanoma, the median age (interquartile range) was 57 (46, 67) years old and 51% were males.
Regarding nevus counts, 57.
9% of patients had 0–25 nevi (low), while the remaining 42.
1% had greater than 25 nevi (high).
In multivariate analysis, those with greater than 25 nevi (versus ≤25) were significantly less likely to have melanoma developing on the head/neck (chronically sun exposed body site) [odds ratio (OR): 0.
60, 95% confidence interval (CI): 0.
38–0.
93] or on the lower extremity (OR: 0.
63, 95% CI: 0.
44-–0.
87), compared with having melanoma on the trunk (non-chronically sun exposed).
Regarding the melanoma subtype, those with SSM versus nodular melanoma subtype were 53% less likely to have melanoma developing on the head/neck (OR: 0.
47, 95% CI: 0.
30–0.
75), compared with the trunk.
The melanoma subtype (SSM or nodular melanoma) did not significantly differ across upper extremity (OR: 0.
94, 95% CI: 0.
59–1.
51) or lower extremity (OR: 1.
03, 95% CI: 0.
66–1.
62) locations of melanoma development compared with the trunk.
In conclusion, the association of higher nevus counts with melanomas developing on the trunk supports the divergent pathways of melanoma development in Southern European patients.
Melanomas on the head/neck were significantly associated with lower numbers of nevi and were more likely to be nodular melanoma subtype.
Related Results
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract
Background: The etiology of melanoma has generally been thought to be exposure to UV radiation (sun and sun tanning lamps). However, the percent of melanoma...
Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent
Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent
Abstract
Melanoma is strongly associated with exposure to ultraviolet radiation (UV). The prevalence of melanoma is much higher in lighter-skinned Caucasians as comp...
Precursors of skin melanoma (melanoma-sensitive nevi)
Precursors of skin melanoma (melanoma-sensitive nevi)
Interest in melanoma precursors, or melanoma-sensitive skin nevi, has not lost its relevance for many years due to the steady increase of skin melanoma morbidity in recent decades ...
Abstract 4342: Histological variants and sites of presentation of malignant melanoma in a resource poor setting: A histopathological review
Abstract 4342: Histological variants and sites of presentation of malignant melanoma in a resource poor setting: A histopathological review
Abstract
Background: Melanoma is a malignant tumour that arises from melanocytic cells. The incidence is increasing worldwide in white population where fair skin peo...
Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma.
Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma.
Abstract
Several lines of experimental evidence have demonstrated the importance of the tumor microenvironment in controlling melanoma tumor growth and melanoma meta...
Pyridinium derivatives for metastatic melanoma therapy
Pyridinium derivatives for metastatic melanoma therapy
<p>Melanoma incidence is increasing faster than any other cancer worldwide.1 Early detection is often curative, but metastatic melanoma is lethal (5-year survival <20%) du...
Abstract 1143: Pro-proliferative function of SIRT3 in a human melanoma xenograft mouse model
Abstract 1143: Pro-proliferative function of SIRT3 in a human melanoma xenograft mouse model
Abstract
Melanoma is one of the most aggressive forms of skin cancer and is often lethal, if not treated early. Therefore, it is necessary to try to develop novel ta...
Modeling melanoma in reconstructed human skin
Modeling melanoma in reconstructed human skin
With increasing pressure from the European Union to replace, reduce, and refine animal experiments, there is a critical need for models that reliably mimic human diseases in a phys...

